humanitarian
Archived signal Translated · Русский · 2–5m lag
Доклад об оценке состояния окружающей среды в Европе: Ruxolitinib Krka, ruxolitinib, Status: Opinion
Доклад об оценке состояния окружающей среды в Европе: Фесго, пертузумаб, трастузумаб, дата получения разрешения: 21/12/2020, пересмотр: 8, статус: санкционировано
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewДоклад об оценке состояния окружающей среды в Европе: Ruxolitinib Krka, ruxolitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Donrafylix, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Fondaparinux Sodium Evumed, fondaparinux sodium, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Baxfendy, baxdrostat, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Garzulys, insulin aspart, Status: OpinionEMA What Is NewДоклад об оценке состояния здоровья населения Европы (EPAR): KemSu, sufentanil,ketamin, Status: RefuledEMA What Is NewHuman medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: RefusedEMA What Is NewДоклад об оценке состояния окружающей среды в Европе: Ruxolitinib Krka, ruxolitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Donrafylix, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Zybrivo, sintilimab, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Fondaparinux sodium Evumed, fondaparinux sodium, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Amlypave, anselamimab, Status: Application withdrawn5 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources